Sharma V K, Bailey D M, Raufman J P, Elraie K, Metz D C, Go M F, Schoenfeld P, Smoot D T, Howden C W
Division of Digestive Diseases, University of Arkansas for Medical Sciences, Little Rock 72205-7199, USA.
Am J Gastroenterol. 2000 Aug;95(8):1914-9. doi: 10.1111/j.1572-0241.2000.02247.x.
Despite recently published national guidelines, many physicians have only limited knowledge about Helicobacter pylori infection. We conducted this study to assess internal medicine residents' knowledge about H. pylori.
Two hundred and nineteen residents in seven accredited internal medicine training programs completed a self-administered questionnaire on personal demographics and practices related to testing for-and treating-H. pylori infection.
Noon conferences (82%), ward teaching (66%), journals (70%), and sponsored symposia (27%) were their major sources of H. pylori-related information. Forty-eight percent had used office-based tests for the infection. Testing for (and treatment of) Helicobacter pylori infection was recommended by 97% (97%) for newly diagnosed duodenal ulcer, but by only 61% (63%) for a past history of duodenal ulcer. Many recommended testing in unproven conditions and might not have offered treatment to an infected patient. A proton pump inhibitor-based triple-drug regimen was the treatment of first choice of 55%; 20% recommended proton pump inhibitor-based dual regimens. Sixty-six percent and 80%, respectively, underestimated the rates of resistance to clarithromycin and metronidazole. In the absence of gastrointestinal symptoms, 22% would have ordered Helicobacter pylori testing but only 33% of these would undergo treatment if positive.
Internal medicine residents usually test for Helicobacter pylori infection in appropriate conditions, but may not always treat the infection when the result is positive. Most use efficacious treatment regimens although many have inaccurate knowledge of resistance rates, which may adversely influence prescribing. Education should focus on practical issues surrounding Helicobacter pylori testing and treatment such as those contained in the American College of Gastroenterology's 1998 practice guidelines.
尽管近期已发布了全国性指南,但许多医生对幽门螺杆菌感染的了解仍然有限。我们开展本研究以评估内科住院医师对幽门螺杆菌的了解情况。
来自7个经认可的内科培训项目的219名住院医师完成了一份关于个人人口统计学信息以及与幽门螺杆菌感染检测和治疗相关实践的自填式问卷。
午间会议(82%)、病房教学(66%)、期刊(70%)和赞助研讨会(27%)是他们获取幽门螺杆菌相关信息的主要来源。48%的人曾使用门诊检测来诊断该感染。对于新诊断的十二指肠溃疡患者,97%(97%)的人建议检测(并治疗)幽门螺杆菌感染,但对于有十二指肠溃疡病史的患者,只有61%(63%)的人这样建议。许多人在未经证实的情况下推荐检测,而且可能不会对感染患者进行治疗。基于质子泵抑制剂的三联药物疗法是55%的人的首选治疗方法;20%的人推荐基于质子泵抑制剂的双联疗法。分别有66%和80%的人低估了克拉霉素和甲硝唑的耐药率。在没有胃肠道症状的情况下,22%的人会安排幽门螺杆菌检测,但如果检测结果为阳性,其中只有33%的人会接受治疗。
内科住院医师通常会在适当情况下检测幽门螺杆菌感染,但检测结果为阳性时可能并不总是进行治疗。大多数人使用有效的治疗方案,尽管许多人对耐药率的认识不准确,这可能会对处方产生不利影响。教育应侧重于围绕幽门螺杆菌检测和治疗的实际问题,例如美国胃肠病学会1998年实践指南中所包含的内容。